Maharashtra, Delhi Among 5 States To Receive First Batch Of COVID-19 Drug

Effects of Covid-19 on Maharashtra and India's business and labour ...

New Delhi: 25 June 2020 Hyderabad-based drugmaker Hetero, which has approval to manufacture and market the generic version of the experimental COVID-19 drug Remdesivir, has sent 20,000 vials to five states including Maharashtra and Delhi – the two worst affected states in the country.

Gujarat and Tamil Nadu are the other two states that will receive the first batch of the drug which is being marketed under the brand name COVIFOR in India. Telangana’s capital Hyderabad, where the drugmaker is based, will also receive the first consignment.

Hetero said a 100-milligram vial of the drug will cost Rs 5,400. The recommended dose for adults and pediatric patients is 200 mg on Day 1 followed by once daily maintenance doses of 100 mg for five days.

Leave a Reply

Your email address will not be published.